InVitro International (IVRO) announced its Ocular Irritection (OI) test has been adopted by the Organization for Economic Cooperation and Development (OECD), and is available for immediate use globally under Test Guideline (TG 496).
OECD is viewed as a regulatory body for in vitro test methods. The method’s adoption by the OECD and its 36 member countries is the result of an 11-year effort. The OI test is part of IVRO’s Irritection Assay System (IAS), which includes the companion Irritection Dermal test method for skin irritancy.
W. Richard Ulmer, CEO of IVRO, commented on OI’s globally accepted status. “It has been a lengthy yet very rewarding process to gain OECD final adoption. In 1985, IVRO pioneered cruelty-free test methods when there was not even one specific regulatory body to set standards or approve test methods anywhere in the world. Now 35 years later, OECD adoption represents the highest scientific review level for any non-animal test method.”
IVRO president, Atul Jhalani added, “In our minds, OECD’s (TG 496) OI adoption provides IVRO’s Irritection technology fresh legal and scientific credibility. With Corrositex, we now have two commercialized in vitro test methods that are globally accepted. . .
Published by Cosmetics & Toileteries, March 17, 2020
GBA Group is a leading group of laboratories with a solid reputation backed by over…
Now, INTECH CO. developed stripping tape to collect Dead skin cell. - Basic Skin Research…
K-Beauty's Global Takeover: A Success Story The Korean beauty industry has achieved an unprecedented milestone:…